MD

Mednax
NYSE

Real-time Quotes | Nasdaq Last Sale

18.43
-0.12
-0.65%
After Hours: 18.43 0 0.00% 16:27 05/19 EDT
OPEN
18.20
PREV CLOSE
18.55
HIGH
18.84
LOW
18.10
VOLUME
975.08K
TURNOVER
0
52 WEEK HIGH
35.68
52 WEEK LOW
17.17
MARKET CAP
1.61B
P/E (TTM)
19.33
1D
5D
1M
3M
1Y
5Y
Mednax names internal executive as COO
Mednax (NYSE:MD) announced two appointments to strengthen its operating and clinical leadership. James D. Swift, M.D. is appointed as COO and Curtis B. Pickert, M.D. as Chief Physician Executive. Both have been with
Seekingalpha · 1d ago
Mednax Announces Leadership Appointments
FORT LAUDERDALE, Fla., May 18, 2022--Mednax Announces Leadership Appointments
Business Wire · 1d ago
Mednax Names Long-Time Execs as COO, Chief Physician
MT Newswires · 1d ago
Mednax Names James Swift Chief Operating Officer
MT Newswires · 2d ago
--SVB Securities Adjusts Mednax's Price Target to $20 from $24, Keeps Market Perform Rating
MT Newswires · 05/12 10:08
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Zacks · 05/10 15:35
--Deutsche Bank Adjusts Price Target on Mednax to $16 From $24, Maintains Sell Rating
MT Newswires · 05/10 09:16
Does The Market Have A Low Tolerance For MEDNAX, Inc.'s (NYSE:MD) Mixed Fundamentals?
It is hard to get excited after looking at MEDNAX's (NYSE:MD) recent performance, when its stock has declined 22% over...
Simply Wall St. · 05/04 10:40
More
No Data
Learn about the latest financial forecast of MD. Analyze the recent business situations of Mednax through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 12 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

8.33%Strong Buy
8.33%Buy
58.33%Hold
25.00%Under-perform
0.00%Sell
Analyst Price Target
The average MD stock price target is 21.90 with a high estimate of 30.00 and a low estimate of 14.00.
High30.00
Average21.90
Low14.00
Current 18.43
EPS
Actual
Estimate
0.130.260.390.52
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 378
Institutional Holdings: 95.34M
% Owned: 109.26%
Shares Outstanding: 87.26M
TypeInstitutionsShares
Increased
69
4.03M
New
21
247.02K
Decreased
83
2.66M
Sold Out
34
2.48M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.47%
Healthcare Providers & Services
+1.01%
Key Executives
Non-Executive Chairman/Independent Director
Guy Sansone
Chief Executive Officer/Director
Mark Ordan
Chief Financial Officer/Executive Vice President
C. Marc Richards
Corporate Executive
Roger Hinson
Chief Operating Officer/Executive Vice President
James Swift
Executive Vice President/General Counsel/Secretary
Dominic Andreano
Executive Vice President
Mary Ann Moore
Other
Curtis Pickert
Director
Roger Medel
Independent Director
Thomas Mceachin
Independent Director
Michael Rucker
Independent Director
John Starcher
Independent Director
Shirley Weis
No Data
No Data
About MD
Mednax, Inc. is a provider of physician services including newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The Company's national network comprises of affiliated physicians who provide clinical care in approximately 39 states and Puerto Rico. Its affiliated physicians provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications; and maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. Its network also includes other pediatric subspecialists, including those who provides pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care, pediatric ear, nose and throat, pediatric ophthalmology, pediatric urology services and pediatric urgent care.

Webull offers kinds of MEDNAX Inc stock information, including NYSE:MD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MD stock methods without spending real money on the virtual paper trading platform.